Life Science Legal ApS — Credit Rating and Financial Key Figures
CVR number: 30738276
Stærmosevej 12 A, 7120 Vejle Øst
ch@isd-immunotech.com
tel: 60734254
www.isd-immunotech.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 3 067.30 | 167.66 | 564.96 | 2 289.20 | 854.26 |
Employee benefit expenses | - 318.69 | -1 285.55 | -1 970.77 | -1 793.23 | - 175.98 |
Total depreciation | -14 918.98 | - 250.00 | |||
EBIT | 2 748.61 | -1 117.90 | -1 405.82 | -14 423.01 | 428.28 |
Other financial income | 25.70 | 0.24 | 8.21 | -4.34 | 810.27 |
Other financial expenses | - 211.22 | - 205.34 | - 263.61 | - 171.21 | -63.13 |
Pre-tax profit | 2 563.08 | -1 323.00 | -1 661.22 | -14 598.56 | 1 175.42 |
Income taxes | - 343.00 | 562.86 | 604.22 | 1 299.00 | |
Net earnings | 2 220.08 | - 760.13 | -1 057.00 | -13 299.56 | 1 175.42 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Development expenditure | 3 604.99 | 8 811.83 | 12 972.03 | 250.00 | |
Intangible assets total | 3 604.99 | 8 811.83 | 12 972.03 | 250.00 | |
Tangible assets total | |||||
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 451.79 | ||||
Prepayments and accrued income | 8.53 | 29.93 | 7.68 | 3.74 | 1.91 |
Current other receivables | 186.62 | 915.63 | 33.21 | 40.66 | |
Current deferred tax assets | 908.87 | 820.22 | 394.00 | ||
Short term receivables total | 195.16 | 1 854.42 | 861.11 | 438.40 | 453.70 |
Cash and bank deposits | 5 292.68 | 8 880.07 | 5 519.06 | 1 040.06 | 560.03 |
Cash and cash equivalents | 5 292.68 | 8 880.07 | 5 519.06 | 1 040.06 | 560.03 |
Balance sheet total (assets) | 9 092.82 | 19 546.32 | 19 352.19 | 1 728.46 | 1 013.73 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 186.99 | 224.98 | 224.98 | 224.98 | 224.98 |
Shares repurchased | 422.00 | ||||
Other reserves | 2 811.89 | 6 873.23 | 10 118.19 | - 122.00 | |
Retained earnings | 1 756.20 | 7 700.66 | 3 695.57 | 12 756.75 | -1 086.81 |
Profit of the financial year | 2 220.08 | - 760.13 | -1 057.00 | -13 299.56 | 1 175.42 |
Shareholders equity total | 6 975.16 | 14 038.73 | 12 981.73 | - 317.83 | 613.59 |
Provisions | 343.00 | 689.00 | 905.00 | ||
Capital loans | 1 060.00 | 873.60 | 1 191.02 | ||
Non-current loans from credit institutions | 1 550.14 | 1 635.19 | |||
Non-current deferred tax liabilities | 1 889.01 | ||||
Non-current liabilities total | 1 060.00 | 2 423.74 | 2 826.21 | 1 889.01 | |
Current loans from credit institutions | 777.92 | 580.12 | 0.44 | ||
Current trade creditors | 521.50 | 230.45 | 354.24 | 70.30 | 32.25 |
Other non-interest bearing current liabilities | 193.16 | 90.13 | 86.89 | 86.98 | 367.45 |
Accruals and deferred income | 1 296.36 | 1 618.01 | |||
Current liabilities total | 714.67 | 2 394.85 | 2 639.26 | 157.28 | 400.14 |
Balance sheet total (liabilities) | 9 092.82 | 19 546.32 | 19 352.19 | 1 728.46 | 1 013.73 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.